---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-148151"
form_type: "8-K"
ticker: "VOR"
cik: "0001817229"
company_name: "Vor Biopharma Inc."
filed_at: "2024-05-28T23:59:59+00:00"
generated_at: "2026-06-01T08:11:39.164924+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Vor Biopharma shareholders approve equity plan amendment to 5% annual share increase, elect directors

## Summary
- Shareholders approved amended 2021 Equity Incentive Plan raising automatic annual share increase from 4% to 5% through 2034.
- Robert Ang and Sven (Bill) Ante Lundberg were elected as Class III directors until the 2027 annual meeting.
- Ernst & Young ratified as independent auditor for fiscal year 2024.
- Plan amendment received 36.8M votes for, 20.9M against; 4.4M broker non-votes.

## SEC filing metadata
- accession: 0001193125-24-148151
- form_type: 8-K
- ticker: VOR
- cik: 0001817229
- company_name: Vor Biopharma Inc.
- filed_at: 2024-05-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817229/000119312524148151/0001193125-24-148151-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817229/000119312524148151/d829841d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-148151
- JSON: https://secwatch.observer/filing/0001193125-24-148151.json
- Plain text: https://secwatch.observer/filing/0001193125-24-148151.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.